{ "dataset": { "name": "Clinical Trial Tracker: Metabolic & Aesthetic Medicine", "url": "https://nphla.com/trackers/clinical-trial-tracker", "description": "Clinical trials followed in metabolic and aesthetic medicine — obesity and incretin therapies, neurotoxins, dermal fillers, regenerative treatments and hair restoration — with each study’s status, phase and latest registry update.", "publisher": "National Pharmacy Health & Leadership Alliance", "howToCite": "National Pharmacy Health & Leadership Alliance (NPHLA). nphla.com. “Clinical Trial Tracker: Metabolic & Aesthetic Medicine.” Updated Oct 1, 2026. https://nphla.com/trackers/clinical-trial-tracker. Accessed October 1, 2026.", "kind": "Clinical trials (ClinicalTrials.gov)", "dataOrigin": "NPHLA analysis of public data", "jurisdiction": "International / multiple", "methodology": "The Intelligence pipeline queries the ClinicalTrials.gov API (version 2) for two broad searches — obesity and incretin therapies, and aesthetic and regenerative medicine (botulinum toxin, dermal fillers, polynucleotides, exosomes, platelet-rich plasma) — and for every topic with a trial query, on the schedule set in the Source Registry. Each study is stored with its registry fields as published. Changes in overall status and newly posted results are recorded with the date the pipeline detected them.\n\nThis tracker lists every tracked study whose last registry update falls within the past 365 days, newest first. Nothing in the table is edited by hand.", "coverage": "Studies on ClinicalTrials.gov — from the United States and other countries — that match the configured searches, from the date tracking began. Studies registered elsewhere, described with other terms, or not updated in the last year are not included.", "limitations": "Registry data is supplied by sponsors and may be incomplete or out of date. Inclusion reflects search terms, not clinical importance. Every therapy in a trial is investigational for the use being studied. Not medical advice.", "updateFrequency": "Registry searches run every 6 to 12 hours, as configured in the Source Registry.", "selection": "ClinicalTrials.gov studies followed by Trial Watch dated within the last 365 days.", "systemCheckedAt": "2026-10-01T15:35:08.009Z", "editoriallyReviewedAt": null, "editorialReview": "pending", "generatedAt": "2026-10-01T20:28:38.508Z", "recordCount": 187, "notAdvice": "Professional information compiled from public sources. Not medical, legal or regulatory advice; always confirm in the primary source." }, "columns": [ { "key": "phase", "label": "Phase" }, { "key": "sponsor", "label": "Sponsor" } ], "records": [ { "key": "trial:NCT06790225", "record": "GINEBRA: Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)", "subtitle": "NCT06790225", "detail": "Conditions: Bone Disease, Metabolic; Diabetes Mellitus, Type 2; Obesity and Obesity-related Medical Conditions. Interventions: Glucose-dependent Insulinotropic Polypeptide (GIP)", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Esbjerg Hospital - University Hospital of Southern Denmark", "enrollment": "13", "nctId": "NCT06790225" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06790225", "url": "https://clinicaltrials.gov/study/NCT06790225", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.479Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07734792", "record": "TOPAZ: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial", "subtitle": "NCT07734792", "detail": "Conditions: Acute Ischemic Stroke (AIS). Interventions: Tirzepatide; Standard Medical Care (SMC)", "status": "Not yet recruiting", "fields": { "phase": "Phase 2 / Phase 3", "sponsor": "yifang zhu", "enrollment": "726", "nctId": "NCT07734792" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07734792", "url": "https://clinicaltrials.gov/study/NCT07734792", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.468Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06632444", "record": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "subtitle": "NCT06632444", "detail": "Conditions: Metabolic Dysfunction Associated Steatohepatitis (MASH); Liver Fibrosis. Interventions: Survodutide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Boehringer Ingelheim", "enrollment": "1800", "nctId": "NCT06632444" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06632444", "url": "https://clinicaltrials.gov/study/NCT06632444", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.458Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06184633", "record": "DUTCH-WAIST: DUTCH Weight Control in Atrial Fibrillation Study", "subtitle": "NCT06184633", "detail": "Conditions: Atrial Fibrillation; Obesity; Weight Loss. Interventions: Semaglutide 3.2 MG/ML; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 4", "sponsor": "Rijnstate Hospital", "enrollment": "280", "nctId": "NCT06184633" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06184633", "url": "https://clinicaltrials.gov/study/NCT06184633", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.447Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07112872", "record": "A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes", "subtitle": "NCT07112872", "detail": "Conditions: Type 2 Diabetes Mellitus. Interventions: RO7795081; Semaglutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Hoffmann-La Roche", "enrollment": "330", "nctId": "NCT07112872" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07112872", "url": "https://clinicaltrials.gov/study/NCT07112872", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.436Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07793929", "record": "A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide", "subtitle": "NCT07793929", "detail": "Conditions: End Stage Renal Disease; Renal Impairment; Obesity; Overweight. Interventions: Ribupatide", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Kailera", "enrollment": "32", "nctId": "NCT07793929" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07793929", "url": "https://clinicaltrials.gov/study/NCT07793929", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.424Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07820358", "record": "SWIFT: Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer", "subtitle": "NCT07820358", "detail": "Conditions: Endometrial Atypical Hyperplasia; Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia; Endometrial Cancer Stage I; Endo…. Interventions: Semaglutide (Wegovy) weekly injection; LNG-IUD (Progestin); Structured Weight Loss Program", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "The Methodist Hospital Research Institute", "enrollment": "48", "nctId": "NCT07820358" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07820358", "url": "https://clinicaltrials.gov/study/NCT07820358", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.366Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06109311", "record": "ACHIEVE-5: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor", "subtitle": "NCT06109311", "detail": "Conditions: Type 2 Diabetes. Interventions: Orforglipron; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "546", "nctId": "NCT06109311" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06109311", "url": "https://clinicaltrials.gov/study/NCT06109311", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.356Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05254314", "record": "GATA-3: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)", "subtitle": "NCT05254314", "detail": "Conditions: Asthma. Interventions: Semaglutide Pen Injector 2.4mg weekly; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Vanderbilt University Medical Center", "enrollment": "100", "nctId": "NCT05254314" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05254314", "url": "https://clinicaltrials.gov/study/NCT05254314", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.345Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07775404", "record": "Elecoglipron: A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus", "subtitle": "NCT07775404", "detail": "Conditions: Obesity; Overweight. Interventions: Elecoglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "AstraZeneca", "enrollment": "351", "nctId": "NCT07775404" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07775404", "url": "https://clinicaltrials.gov/study/NCT07775404", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.325Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07752979", "record": "Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities", "subtitle": "NCT07752979", "detail": "Conditions: Obesity; Overweight. Interventions: ABBV-295; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "AbbVie", "enrollment": "360", "nctId": "NCT07752979" }, "jurisdiction": null, "date": "2026-10-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07752979", "url": "https://clinicaltrials.gov/study/NCT07752979", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.388Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06323174", "record": "REIMAGINE 1: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise", "subtitle": "NCT06323174", "detail": "Conditions: Type 2 Diabetes. Interventions: Cagrilintide; Semaglutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "189", "nctId": "NCT06323174" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06323174", "url": "https://clinicaltrials.gov/study/NCT06323174", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.780Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07817251", "record": "Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema", "subtitle": "NCT07817251", "detail": "Conditions: Diabetes Mellitus, Type 2. Interventions: CagriSema", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "210", "nctId": "NCT07817251" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07817251", "url": "https://clinicaltrials.gov/study/NCT07817251", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.750Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04011748", "record": "Clinical Application of Stem Cell Educator Therapy in Alopecia Areata", "subtitle": "NCT04011748", "detail": "Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis. Interventions: Stem Cell Educator therapy", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Throne Biotechnologies Inc.", "enrollment": "20", "nctId": "NCT04011748" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04011748", "url": "https://clinicaltrials.gov/study/NCT04011748", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.155Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07850011", "record": "Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE)", "subtitle": "NCT07850011", "detail": "Conditions: Androgenetic Alopecia; Cicatricial Alopecia. Interventions: Integrated Evidence-Based FUE Protocol; Standard FUE Practice", "status": "Not yet recruiting", "fields": { "phase": "Not applicable", "sponsor": "Assiut University", "enrollment": "30", "nctId": "NCT07850011" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07850011", "url": "https://clinicaltrials.gov/study/NCT07850011", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.130Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07849348", "record": "Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria", "subtitle": "NCT07849348", "detail": "Conditions: Obesity; Chronic Kidney Disease; Albuminuria. Interventions: Finerenone; Finerenone Placebo; Semaglutide", "status": "Not yet recruiting", "fields": { "phase": "Not applicable", "sponsor": "Peking University People's Hospital", "enrollment": "266", "nctId": "NCT07849348" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07849348", "url": "https://clinicaltrials.gov/study/NCT07849348", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.500Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07011667", "record": "A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term", "subtitle": "NCT07011667", "detail": "Conditions: Obesity. Interventions: CagriSema (Cagrilintide B and Semaglutide I); Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "609", "nctId": "NCT07011667" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07011667", "url": "https://clinicaltrials.gov/study/NCT07011667", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.753Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07850050", "record": "SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight", "subtitle": "NCT07850050", "detail": "Conditions: Obesity. Interventions: Survodutide; Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Boehringer Ingelheim", "enrollment": "600", "nctId": "NCT07850050" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07850050", "url": "https://clinicaltrials.gov/study/NCT07850050", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.792Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07781371", "record": "SCALA-TK-CM: A Retrospective Real-World Cohort Study", "subtitle": "NCT07781371", "detail": "Conditions: Obesity; Type 2 Diabetes (T2D); Prediabetes; Cardiovascular Disease (CVD); Dyslipidemia; Metabolic Dysfunction-associated Steatotic Liver D…. Interventions: No treatment given", "status": "Active, not recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Novo Nordisk A/S", "enrollment": "100000", "nctId": "NCT07781371" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07781371", "url": "https://clinicaltrials.gov/study/NCT07781371", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.716Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07564414", "record": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "subtitle": "NCT07564414", "detail": "Conditions: Obesity; Type 2 Diabetes. Interventions: Cagrisema; Semaglutide", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "2500", "nctId": "NCT07564414" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07564414", "url": "https://clinicaltrials.gov/study/NCT07564414", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.690Z", "change": null, "origin": "automated" }, { "key": "trial:NCT03449251", "record": "DEFINE: A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin", "subtitle": "NCT03449251", "detail": "Conditions: Cardiovascular Diseases; Type 2 Diabetes Mellitus. Interventions: Apelin; Relaxin; Normal saline; Verapamil; LN Monomethyl arginine", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Cambridge University Hospitals NHS Foundation Trust", "enrollment": "170", "nctId": "NCT03449251" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT03449251", "url": "https://clinicaltrials.gov/study/NCT03449251", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.680Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07850063", "record": "ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease", "subtitle": "NCT07850063", "detail": "Conditions: Obesity; Metabolic Dysfunction-associated Steatotic Liver Disease. Interventions: Survodutide; Placebo matching survodutide", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Boehringer Ingelheim", "enrollment": "600", "nctId": "NCT07850063" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07850063", "url": "https://clinicaltrials.gov/study/NCT07850063", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.920Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07850466", "record": "TRPTI Metabolic and GLP-1 Pharmacodynamic Study", "subtitle": "NCT07850466", "detail": "Conditions: Overweight , Obesity. Interventions: TRPTI; Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "RDC Clinical Pty Ltd", "enrollment": "20", "nctId": "NCT07850466" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07850466", "url": "https://clinicaltrials.gov/study/NCT07850466", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.945Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04966299", "record": "EryAdo: Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents", "subtitle": "NCT04966299", "detail": "Conditions: Insulin Resistance; Glucose Tolerance; Body Composition; Gastrointestinal Tolerance; Thrombocyte Aggregation; Blood p-Selectin; Blood Eryth…. Interventions: Erythritol; Sucrose; Glucose; Fructose; Xylitol; Water", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "University Hospital, Basel, Switzerland", "enrollment": "30", "nctId": "NCT04966299" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04966299", "url": "https://clinicaltrials.gov/study/NCT04966299", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.887Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06854614", "record": "STAY-LEAN: Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)", "subtitle": "NCT06854614", "detail": "Conditions: Obesity. Interventions: Comprehensive weight loss; Enhanced lifestyle changes; Tirzepatide; Naltrexone-Bupropion; Phentermine-Topiramate; Semag…", "status": "Active, not recruiting", "fields": { "phase": "Phase 4", "sponsor": "The Cleveland Clinic", "enrollment": "150", "nctId": "NCT06854614" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06854614", "url": "https://clinicaltrials.gov/study/NCT06854614", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.564Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07253285", "record": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "subtitle": "NCT07253285", "detail": "Conditions: Overweight; Obesity. Interventions: Cagrilintide; Semaglutide; Placebo cagrilintide; Placebo semaglutide", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "460", "nctId": "NCT07253285" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07253285", "url": "https://clinicaltrials.gov/study/NCT07253285", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.850Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07280221", "record": "WEgovy Real World Assessment of Weight Loss in Korea", "subtitle": "NCT07280221", "detail": "Conditions: Obesity. Interventions: Semaglutide", "status": "Enrolling by invitation", "fields": { "phase": "Phase not stated", "sponsor": "Novo Nordisk A/S", "enrollment": "500", "nctId": "NCT07280221" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07280221", "url": "https://clinicaltrials.gov/study/NCT07280221", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.599Z", "change": null, "origin": "automated" }, { "key": "trial:NCT03596450", "record": "Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial", "subtitle": "NCT03596450", "detail": "Conditions: Diabetes Mellitus, Type 2. Interventions: Semaglutide; Standard of care", "status": "Completed", "fields": { "phase": "Phase 4", "sponsor": "Novo Nordisk A/S", "enrollment": "1278", "nctId": "NCT03596450" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT03596450", "url": "https://clinicaltrials.gov/study/NCT03596450", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.815Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07850765", "record": "Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets", "subtitle": "NCT07850765", "detail": "Conditions: Overweight; Obesity. Interventions: Semaglutide", "status": "Completed", "fields": { "phase": "Phase not stated", "sponsor": "Novo Nordisk A/S", "enrollment": "1260", "nctId": "NCT07850765" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07850765", "url": "https://clinicaltrials.gov/study/NCT07850765", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.604Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06077864", "record": "A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)", "subtitle": "NCT06077864", "detail": "Conditions: Obesity. Interventions: survodutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Boehringer Ingelheim", "enrollment": "5531", "nctId": "NCT06077864" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06077864", "url": "https://clinicaltrials.gov/study/NCT06077864", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.538Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05567796", "record": "REDEFINE 1: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight", "subtitle": "NCT05567796", "detail": "Conditions: Obesity. Interventions: Cagrilintide; Semaglutide; Placebo cagrilintide; Placebo semaglutide", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "3400", "nctId": "NCT05567796" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05567796", "url": "https://clinicaltrials.gov/study/NCT05567796", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T15:35:07.322Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T15:35:07.641Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07849205", "record": "AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality", "subtitle": "NCT07849205", "detail": "Conditions: Skin Aging; Skin Quality. Interventions: Mechanical microneedling; AnteAGE Exosomes and PEARL Multiplier; AnteAGE Homecare Regimen", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Cellese Inc.", "enrollment": "12", "nctId": "NCT07849205" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07849205", "url": "https://clinicaltrials.gov/study/NCT07849205", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.861Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07849556", "record": "AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation", "subtitle": "NCT07849556", "detail": "Conditions: Skin Aging; Facial Rhytides; Skin Tone. Interventions: AnteAGE Biosome Treatment Solution; Radiofrequency Microneedling; AnteAGE Homecare Regimen", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Cellese Inc.", "enrollment": "30", "nctId": "NCT07849556" }, "jurisdiction": null, "date": "2026-09-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07849556", "url": "https://clinicaltrials.gov/study/NCT07849556", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.838Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06771115", "record": "Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity", "subtitle": "NCT06771115", "detail": "Conditions: Obesity. Interventions: Placebo; VTX3232 30 mg; Placebo in combination with semaglutide; VTX3232 30 mg in combination with semaglutide", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Zomagen Biosciences Ltd.", "enrollment": "175", "nctId": "NCT06771115" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06771115", "url": "https://clinicaltrials.gov/study/NCT06771115", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:21.027Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07527910", "record": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "subtitle": "NCT07527910", "detail": "Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Interventions: ALN-PNP; Tirzepatide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "Regeneron Pharmaceuticals", "enrollment": "204", "nctId": "NCT07527910" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07527910", "url": "https://clinicaltrials.gov/study/NCT07527910", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.881Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05305794", "record": "TOLEDDO: Effect of Weekly GLP1 Agonist Treatment in \"Double Diabetes\"", "subtitle": "NCT05305794", "detail": "Conditions: Double Diabetes. Interventions: Insulin + semaglutide treatment; Usual insulin treatment; Biological check-up", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Centre Hospitalier Universitaire Dijon", "enrollment": "76", "nctId": "NCT05305794" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05305794", "url": "https://clinicaltrials.gov/study/NCT05305794", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.826Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07845500", "record": "A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity", "subtitle": "NCT07845500", "detail": "Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity. Interventions: Semaglutide; Tirzepatide; Berobenatide", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Pfizer", "enrollment": "660", "nctId": "NCT07845500" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07845500", "url": "https://clinicaltrials.gov/study/NCT07845500", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:21.086Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06603571", "record": "A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes", "subtitle": "NCT06603571", "detail": "Conditions: Obesity; Overweight. Interventions: LY3841136; Tirzepatide; Placebo", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Eli Lilly and Company", "enrollment": "367", "nctId": "NCT06603571" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06603571", "url": "https://clinicaltrials.gov/study/NCT06603571", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.009Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07847593", "record": "TELWA: Probiotics in Obese Patients Treated With GLP-1 Receptor Agonists", "subtitle": "NCT07847593", "detail": "Conditions: Obesity (Disorder); GLP-1 Receptor Agonist Treatment; Probiotic Intervention; Diabetes Mellitus Type 2. Interventions: Four-strain probiotic formulation; Maltodextrin (Placebo)", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Nordic Biotic Sp. z o.o.", "enrollment": "102", "nctId": "NCT07847593" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07847593", "url": "https://clinicaltrials.gov/study/NCT07847593", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:21.054Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07847515", "record": "Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients", "subtitle": "NCT07847515", "detail": "Conditions: Obesity / Overweight. Interventions: Tirzepatide", "status": "Not yet recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Nanjing First Hospital, Nanjing Medical University", "enrollment": "80", "nctId": "NCT07847515" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07847515", "url": "https://clinicaltrials.gov/study/NCT07847515", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.978Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07171281", "record": "GLYCOTIME: Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes", "subtitle": "NCT07171281", "detail": "Conditions: Prediabetes; Type 2 Diabetes; Obesity &Amp; Overweight. Interventions: Early Time-Restricted Eating; Late Time-Restricted Eating", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "German Institute of Human Nutrition", "enrollment": "30", "nctId": "NCT07171281" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07171281", "url": "https://clinicaltrials.gov/study/NCT07171281", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.129Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.466Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07846865", "record": "TIRZE-PAP: Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial", "subtitle": "NCT07846865", "detail": "Conditions: Sleep Apnoea; Obesity & Overweight; Sleep Apnea Syndrome, Obstructive. Interventions: Continuous Positive Airway Pressure; Tirzepatide", "status": "Not yet recruiting", "fields": { "phase": "Phase 2 / Phase 3", "sponsor": "Woolcock Institute of Medical Research", "enrollment": "256", "nctId": "NCT07846865" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07846865", "url": "https://clinicaltrials.gov/study/NCT07846865", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.943Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07846033", "record": "A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities", "subtitle": "NCT07846033", "detail": "Conditions: Obese Adults. Interventions: SC VK3019; Matching placebo", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Viking Therapeutics, Inc.", "enrollment": "56", "nctId": "NCT07846033" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07846033", "url": "https://clinicaltrials.gov/study/NCT07846033", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.939Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07171723", "record": "SILENCED: Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment", "subtitle": "NCT07171723", "detail": "Conditions: Obesity &Amp; Overweight. Interventions: Liver-Expressed Antimicrobial Peptide 2 (LEAP2); Placebo (saline)", "status": "Completed", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "University Hospital, Gentofte, Copenhagen", "enrollment": "24", "nctId": "NCT07171723" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07171723", "url": "https://clinicaltrials.gov/study/NCT07171723", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:21.004Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06382480", "record": "PROTIME: PROTeIn-rich Meals to Control Glucose", "subtitle": "NCT06382480", "detail": "Conditions: Overweight; Obesity; Prediabetes; Type 2 Diabetes. Interventions: Diet with specific macronutrient composition.", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "German Institute of Human Nutrition", "enrollment": "30", "nctId": "NCT06382480" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06382480", "url": "https://clinicaltrials.gov/study/NCT06382480", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.129Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.368Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07724340", "record": "A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity", "subtitle": "NCT07724340", "detail": "Conditions: Adults With Overweight/Obesity and Type 2 Diabetes. Interventions: AT673 low dose; AT673 high dose; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Antag Therapeutics", "enrollment": "150", "nctId": "NCT07724340" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07724340", "url": "https://clinicaltrials.gov/study/NCT07724340", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.975Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07846956", "record": "NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study", "subtitle": "NCT07846956", "detail": "Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity. Interventions: GLP-1 Receptor Agonist Therapy", "status": "Not yet recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Istanbul Saglik Bilimleri University", "enrollment": "28", "nctId": "NCT07846956" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07846956", "url": "https://clinicaltrials.gov/study/NCT07846956", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.936Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07845578", "record": "A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight", "subtitle": "NCT07845578", "detail": "Conditions: Obesity; Overweight. Interventions: Semaglutide; Placebo semaglutide; Paracetamol", "status": "Not yet recruiting", "fields": { "phase": "Phase 1", "sponsor": "Novo Nordisk A/S", "enrollment": "60", "nctId": "NCT07845578" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07845578", "url": "https://clinicaltrials.gov/study/NCT07845578", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.899Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07685808", "record": "Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes", "subtitle": "NCT07685808", "detail": "Conditions: Overweight or Obesity. Interventions: Olatorepatide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "Regeneron Pharmaceuticals", "enrollment": "360", "nctId": "NCT07685808" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07685808", "url": "https://clinicaltrials.gov/study/NCT07685808", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.129Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.281Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07845994", "record": "SEMAFORCRANIO: SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years", "subtitle": "NCT07845994", "detail": "Conditions: Craniopharyngioma, Child. Interventions: Semaglutide (Wegovy) weekly injection; Placebo weekly Injection", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "University Hospital, Angers", "enrollment": "50", "nctId": "NCT07845994" }, "jurisdiction": null, "date": "2026-09-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07845994", "url": "https://clinicaltrials.gov/study/NCT07845994", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:20.487Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.870Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06745128", "record": "Tirzepatide for Obesity and Meth Use Disorder", "subtitle": "NCT06745128", "detail": "Conditions: Obesity; Methamphetamine Use Disorder. Interventions: Tirzepatide", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "University of Texas Southwestern Medical Center", "enrollment": "35", "nctId": "NCT06745128" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06745128", "url": "https://clinicaltrials.gov/study/NCT06745128", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.132Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06260722", "record": "Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)", "subtitle": "NCT06260722", "detail": "Conditions: Diabetes Mellitus, Type 2. Interventions: Retatrutide; Semaglutide", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1250", "nctId": "NCT06260722" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06260722", "url": "https://clinicaltrials.gov/study/NCT06260722", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.308Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07794579", "record": "ATTAIN-NOW: A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity", "subtitle": "NCT07794579", "detail": "Conditions: Overweight; Prediabetic State; Prehypertension; Obesity, Abdominal. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "2001", "nctId": "NCT07794579" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07794579", "url": "https://clinicaltrials.gov/study/NCT07794579", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.319Z", "change": null, "origin": "automated" }, { "key": "trial:NCT03407079", "record": "Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)", "subtitle": "NCT03407079", "detail": "Conditions: Healthy Volunteers; Overweight. Interventions: Sucralose; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "enrollment": "150", "nctId": "NCT03407079" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT03407079", "url": "https://clinicaltrials.gov/study/NCT03407079", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.129Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.604Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07078838", "record": "Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer", "subtitle": "NCT07078838", "detail": "Conditions: Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma. Interventions: Tirzepatide", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "enrollment": "40", "nctId": "NCT07078838" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07078838", "url": "https://clinicaltrials.gov/study/NCT07078838", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.108Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06861439", "record": "GLOW: GLP-1s to Enhance Lasting Optimal Weight", "subtitle": "NCT06861439", "detail": "Conditions: Obesity. Interventions: Tirzepatide", "status": "Active, not recruiting", "fields": { "phase": "Phase 4", "sponsor": "Wake Forest University Health Sciences", "enrollment": "40", "nctId": "NCT06861439" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06861439", "url": "https://clinicaltrials.gov/study/NCT06861439", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.077Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07802639", "record": "Treatment for \"Asymmetric Crying Facies\"", "subtitle": "NCT07802639", "detail": "Conditions: Hemifacial Microsomia; Facial Nerve Paralysis. Interventions: Botulinium toxin type A injection", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Xiaolei Jin", "enrollment": "60", "nctId": "NCT07802639" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07802639", "url": "https://clinicaltrials.gov/study/NCT07802639", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.649Z", "change": null, "origin": "automated" }, { "key": "trial:NCT02911103", "record": "Deep Brain Stimulation Surgery for Focal Hand Dystonia", "subtitle": "NCT02911103", "detail": "Conditions: Dystonia; Focal Dystonia; Musician's Dystonia. Interventions: DBS surgery; Medtronic Activa Rechargeable System", "status": "Active, not recruiting", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "enrollment": "5", "nctId": "NCT02911103" }, "jurisdiction": null, "date": "2026-09-28T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT02911103", "url": "https://clinicaltrials.gov/study/NCT02911103", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.870Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07835360", "record": "Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes", "subtitle": "NCT07835360", "detail": "Conditions: Obesity (Disorder); Type 2 Diabetes Mellitus", "status": "Recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", "enrollment": "200", "nctId": "NCT07835360" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07835360", "url": "https://clinicaltrials.gov/study/NCT07835360", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.232Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06759701", "record": "Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study", "subtitle": "NCT06759701", "detail": "Conditions: Diabetes; Prostate Cancer. Interventions: Tirzepatide", "status": "Recruiting", "fields": { "phase": "Early phase 1", "sponsor": "M.D. Anderson Cancer Center", "enrollment": "30", "nctId": "NCT06759701" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06759701", "url": "https://clinicaltrials.gov/study/NCT06759701", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.212Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06700538", "record": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "subtitle": "NCT06700538", "detail": "Conditions: Obesity. Interventions: ARO-INHBE; Placebo; Tirzepatide", "status": "Recruiting", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "Arrowhead Pharmaceuticals", "enrollment": "180", "nctId": "NCT06700538" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06700538", "url": "https://clinicaltrials.gov/study/NCT06700538", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.192Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07817875", "record": "Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)", "subtitle": "NCT07817875", "detail": "Conditions: Obesity. Interventions: Tirzepatide; Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "150", "nctId": "NCT07817875" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07817875", "url": "https://clinicaltrials.gov/study/NCT07817875", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.170Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07842640", "record": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight", "subtitle": "NCT07842640", "detail": "Conditions: Chronic Weight Management. Interventions: ASC35 Injection B, for subcutaneous use; ASC35 Placebo Injection B, for subcutaneous use; Tirzepatide", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Ascletis Pharma (China) Co., Limited", "enrollment": "84", "nctId": "NCT07842640" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07842640", "url": "https://clinicaltrials.gov/study/NCT07842640", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.152Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07035093", "record": "TRIUMPH-7: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain", "subtitle": "NCT07035093", "detail": "Conditions: Obesity; Overweight; Chronic Low Back Pain (CLBP). Interventions: Retatrutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "586", "nctId": "NCT07035093" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07035093", "url": "https://clinicaltrials.gov/study/NCT07035093", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.328Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07668336", "record": "ACHIEVE-PEDS: A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes", "subtitle": "NCT07668336", "detail": "Conditions: Diabetes Mellitus, Type 2. Interventions: Orforglipron; Dulaglutide", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "170", "nctId": "NCT07668336" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07668336", "url": "https://clinicaltrials.gov/study/NCT07668336", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.338Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05248893", "record": "A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines", "subtitle": "NCT05248893", "detail": "Conditions: Glabellar Lines. Interventions: AGN-151586", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "AbbVie", "enrollment": "992", "nctId": "NCT05248893" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05248893", "url": "https://clinicaltrials.gov/study/NCT05248893", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.679Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07483320", "record": "Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy", "subtitle": "NCT07483320", "detail": "Conditions: Achilles Injuries Tendon; Achilles Tendinopathy (AT); Achilles Tendinitis, Left Leg; Achilles Tendinitis, Right Leg; Achilles Tendon Pain;…. Interventions: Platelet Rich Plasma; Extracorporeal Shockwave Therapy; Sham PRP; Sham ESWT", "status": "Not yet recruiting", "fields": { "phase": "Not applicable", "sponsor": "Spaulding Rehabilitation Hospital", "enrollment": "100", "nctId": "NCT07483320" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07483320", "url": "https://clinicaltrials.gov/study/NCT07483320", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.897Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07748793", "record": "ASSET: Autologous Fat Grafting for the Treatment of Chronic Tendinopathy", "subtitle": "NCT07748793", "detail": "Conditions: Chronic Tendinopathy. Interventions: Adipose Stem/Stromal Cells for Enthesis/Tendon Therapy (ASSET) Injection", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Weill Medical College of Cornell University", "enrollment": "40", "nctId": "NCT07748793" }, "jurisdiction": null, "date": "2026-09-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07748793", "url": "https://clinicaltrials.gov/study/NCT07748793", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.888Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06937099", "record": "COMMIT-CD: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "subtitle": "NCT06937099", "detail": "Conditions: Crohn's Disease; Obesity or Overweight. Interventions: Mirikizumab; Mirikizumab; Tirzepatide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "290", "nctId": "NCT06937099" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06937099", "url": "https://clinicaltrials.gov/study/NCT06937099", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.312Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07265752", "record": "Tirzepatide for the Treatment of Cannabis Use Disorder", "subtitle": "NCT07265752", "detail": "Conditions: Cannabis Use Disorder. Interventions: Tirzepatide; Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "Brigham and Women's Hospital", "enrollment": "6", "nctId": "NCT07265752" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07265752", "url": "https://clinicaltrials.gov/study/NCT07265752", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.290Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06937086", "record": "COMMIT-UC: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "subtitle": "NCT06937086", "detail": "Conditions: Ulcerative Colitis; Obesity or Overweight. Interventions: Mirikizumab; Mirikizumab; Tirzepatide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "350", "nctId": "NCT06937086" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06937086", "url": "https://clinicaltrials.gov/study/NCT06937086", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.270Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06439277", "record": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "subtitle": "NCT06439277", "detail": "Conditions: Obesity; Weight Gain. Interventions: Tirzepatide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "300", "nctId": "NCT06439277" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06439277", "url": "https://clinicaltrials.gov/study/NCT06439277", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.252Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06383390", "record": "The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)", "subtitle": "NCT06383390", "detail": "Conditions: Atherosclerotic Cardiovascular Disease (ASCVD); Chronic Kidney Disease (CKD). Interventions: Retatrutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "10000", "nctId": "NCT06383390" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06383390", "url": "https://clinicaltrials.gov/study/NCT06383390", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.348Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06672549", "record": "ADVANCE: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)", "subtitle": "NCT06672549", "detail": "Conditions: Obesity; Overweight. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "125", "nctId": "NCT06672549" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06672549", "url": "https://clinicaltrials.gov/study/NCT06672549", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.356Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06131372", "record": "A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo", "subtitle": "NCT06131372", "detail": "Conditions: Chronic Kidney Disease; Type 2 Diabetes; Obesity. Interventions: Cagrilintide; Semaglutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Novo Nordisk A/S", "enrollment": "626", "nctId": "NCT06131372" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06131372", "url": "https://clinicaltrials.gov/study/NCT06131372", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.964Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07838454", "record": "Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome", "subtitle": "NCT07838454", "detail": "Conditions: Sjogren Syndrome; Xerostomia; Exosome. Interventions: exosomes derived from human umbilical cord mesenchymal stem cells; Mesenchymal Stem Cells (MSC); Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "Banu Erkal", "enrollment": "30", "nctId": "NCT07838454" }, "jurisdiction": null, "date": "2026-09-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07838454", "url": "https://clinicaltrials.gov/study/NCT07838454", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.914Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07803744", "record": "A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity", "subtitle": "NCT07803744", "detail": "Conditions: Diabetes Mellitus, Type 1; Overweight; Obesity. Interventions: Tirzepatide; Acetaminophen; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Eli Lilly and Company", "enrollment": "18", "nctId": "NCT07803744" }, "jurisdiction": null, "date": "2026-09-23T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07803744", "url": "https://clinicaltrials.gov/study/NCT07803744", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.846Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:20.332Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06937944", "record": "Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines", "subtitle": "NCT06937944", "detail": "Conditions: Moderate to Severe Glabellar Lines. Interventions: Rcombinant botulinum toxin type A for injection（Eveotox); OnabotulinumtoxinA (Botox); Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "JHM BioPharma (Tonghua) Co. , Ltd.", "enrollment": "669", "nctId": "NCT06937944" }, "jurisdiction": null, "date": "2026-09-23T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06937944", "url": "https://clinicaltrials.gov/study/NCT06937944", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.710Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07791953", "record": "Effect of an Intraoperative Polynucleotide Injection on Scar Quality After Thyroidectomy", "subtitle": "NCT07791953", "detail": "Conditions: Postoperative Surgical Scar; Scar; Scar Formation; Neck Scar. Interventions: Polynucleotide (PN-HPT); Sterile 0.9% Sodium Chloride", "status": "Not yet recruiting", "fields": { "phase": "Not applicable", "sponsor": "Dr. Lutfi Kirdar Kartal Training and Research Hospital", "enrollment": "80", "nctId": "NCT07791953" }, "jurisdiction": null, "date": "2026-09-23T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07791953", "url": "https://clinicaltrials.gov/study/NCT07791953", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.923Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07165028", "record": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "subtitle": "NCT07165028", "detail": "Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease. Interventions: Tirzepatide; Retatrutide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "4500", "nctId": "NCT07165028" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07165028", "url": "https://clinicaltrials.gov/study/NCT07165028", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.367Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07202884", "record": "RESTRAIN-SUI: A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight", "subtitle": "NCT07202884", "detail": "Conditions: Urinary Incontinence,Stress. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1000", "nctId": "NCT07202884" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07202884", "url": "https://clinicaltrials.gov/study/NCT07202884", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.453Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07223593", "record": "ATTAIN-PAD: Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease", "subtitle": "NCT07223593", "detail": "Conditions: Peripheral Arterial Disease. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1205", "nctId": "NCT07223593" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07223593", "url": "https://clinicaltrials.gov/study/NCT07223593", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.433Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07613307", "record": "ACHIEVE-RAM: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting", "subtitle": "NCT07613307", "detail": "Conditions: Diabetes Mellitus, Type 2; Diabetes Melletus; Glucose Metabolism Disorders; Metabolic Disorders; Nutritional and Metabolic Diseases; Endocr…. Interventions: Orforglipron", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "130", "nctId": "NCT07613307" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07613307", "url": "https://clinicaltrials.gov/study/NCT07613307", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.414Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07153471", "record": "ATTAIN-OA PAIN: A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee", "subtitle": "NCT07153471", "detail": "Conditions: Osteoarthritis. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "800", "nctId": "NCT07153471" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07153471", "url": "https://clinicaltrials.gov/study/NCT07153471", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.393Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07241390", "record": "A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)", "subtitle": "NCT07241390", "detail": "Conditions: Atherosclerosis Cardiovascular Disease; Chronic Kidney Disease. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "7140", "nctId": "NCT07241390" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07241390", "url": "https://clinicaltrials.gov/study/NCT07241390", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.375Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07392190", "record": "ENLIGHTEN-6: A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin", "subtitle": "NCT07392190", "detail": "Conditions: Overweight; Obesity. Interventions: Eloralintide; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "900", "nctId": "NCT07392190" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07392190", "url": "https://clinicaltrials.gov/study/NCT07392190", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.981Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04721548", "record": "MINOX: Treatment of Androgenetic Alopecia in Men for 24 Weeks", "subtitle": "NCT04721548", "detail": "Conditions: Alopecia. Interventions: Minoxidil Topical Foam; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eurofarma Laboratorios S.A.", "enrollment": "336", "nctId": "NCT04721548" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04721548", "url": "https://clinicaltrials.gov/study/NCT04721548", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.190Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06393452", "record": "Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA", "subtitle": "NCT06393452", "detail": "Conditions: Androgenetic Alopecia. Interventions: PP405 0.05% Topical Gel; Topical Vehicle Gel", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Pelage Pharmaceuticals, Inc.", "enrollment": "78", "nctId": "NCT06393452" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06393452", "url": "https://clinicaltrials.gov/study/NCT06393452", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.173Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07117955", "record": "Platelet-Rich Plasma for Peyronie's Disease", "subtitle": "NCT07117955", "detail": "Conditions: Peyronies Disease. Interventions: Autologous Platelet Rich Plasma; Saline solution", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Herlev Hospital", "enrollment": "84", "nctId": "NCT07117955" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07117955", "url": "https://clinicaltrials.gov/study/NCT07117955", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.954Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06789510", "record": "Treatment of Peyronie's Disease With Platelet-Rich Plasma", "subtitle": "NCT06789510", "detail": "Conditions: Peyronies Disease. Interventions: Autologous Platelet Rich Plasma; Saline solution", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Herlev Hospital", "enrollment": "10", "nctId": "NCT06789510" }, "jurisdiction": null, "date": "2026-09-22T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06789510", "url": "https://clinicaltrials.gov/study/NCT06789510", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.941Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07225829", "record": "INFLAM MOTION: A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis", "subtitle": "NCT07225829", "detail": "Conditions: Knee Osteoarthritis; Synovitis of Knee. Interventions: 4P004; Placebo (NaCl 0.9%)", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "4Moving Biotech", "enrollment": "129", "nctId": "NCT07225829" }, "jurisdiction": null, "date": "2026-09-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07225829", "url": "https://clinicaltrials.gov/study/NCT07225829", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.846Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07832032", "record": "BioM: Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine", "subtitle": "NCT07832032", "detail": "Conditions: Migraine. Interventions: Rimegepant 75 MG", "status": "Not yet recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Nordlandssykehuset HF", "enrollment": "60", "nctId": "NCT07832032" }, "jurisdiction": null, "date": "2026-09-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07832032", "url": "https://clinicaltrials.gov/study/NCT07832032", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.006Z", "change": null, "origin": "automated" }, { "key": "trial:NCT01072825", "record": "ENIGI: A European Network for the Investigation of Gender Incongruence", "subtitle": "NCT01072825", "detail": "Conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons. Interventions: questionnaires; blood sampling; clinical evaluation; Dermatology evaluation; Bone evaluation", "status": "Recruiting", "fields": { "phase": "Phase not stated", "sponsor": "University Hospital, Ghent", "enrollment": "125", "nctId": "NCT01072825" }, "jurisdiction": null, "date": "2026-09-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT01072825", "url": "https://clinicaltrials.gov/study/NCT01072825", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.207Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05525845", "record": "Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI", "subtitle": "NCT05525845", "detail": "Conditions: Healthy. Interventions: Functional Magnetic Resonance Imaging (pCASL-MRI); Intragastric Balloon; Elemental Meal; Hedonic Meal", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "Mayo Clinic", "enrollment": "15", "nctId": "NCT05525845" }, "jurisdiction": null, "date": "2026-09-18T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05525845", "url": "https://clinicaltrials.gov/study/NCT05525845", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.025Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07819435", "record": "AWAKEN: Phase 2/3 Efficacy and Safety of PP405 in Adult Males", "subtitle": "NCT07819435", "detail": "Conditions: Androgenetic Alopecia. Interventions: PP405 0.05% Topical Gel; Vehicle Topical Gel", "status": "Not yet recruiting", "fields": { "phase": "Phase 2 / Phase 3", "sponsor": "Pelage Pharmaceuticals, Inc.", "enrollment": "600", "nctId": "NCT07819435" }, "jurisdiction": null, "date": "2026-09-18T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07819435", "url": "https://clinicaltrials.gov/study/NCT07819435", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.224Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06807164", "record": "SERCABOT: Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome", "subtitle": "NCT06807164", "detail": "Conditions: Post-Mastectomy Neuropathic Pain Syndrome. Interventions: Capsaicin 8% Patch; Serratus Plane Block; Botulinum Toxin A", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "Centre Oscar Lambret", "enrollment": "123", "nctId": "NCT06807164" }, "jurisdiction": null, "date": "2026-09-17T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06807164", "url": "https://clinicaltrials.gov/study/NCT06807164", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.042Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04653740", "record": "OMERIC: Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer", "subtitle": "NCT04653740", "detail": "Conditions: Advanced Breast Cancer. Interventions: specimen sample collection", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "Centre Oscar Lambret", "enrollment": "25", "nctId": "NCT04653740" }, "jurisdiction": null, "date": "2026-09-17T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04653740", "url": "https://clinicaltrials.gov/study/NCT04653740", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:14.990Z", "change": null, "origin": "automated" }, { "key": "trial:NCT03841981", "record": "Body Fat as Determinant of Female Gonadal Dysfunction", "subtitle": "NCT03841981", "detail": "Conditions: Polycystic Ovary Syndrome; Hypothalamic Amenorrhea. Interventions: Anthropometric and physical examination; Indirect calorimetry, accelerometer and seven-day dietary recall; Biochemical,…", "status": "Completed", "fields": { "phase": "Phase not stated", "sponsor": "Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal", "enrollment": "50", "nctId": "NCT03841981" }, "jurisdiction": null, "date": "2026-09-16T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT03841981", "url": "https://clinicaltrials.gov/study/NCT03841981", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.043Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05888922", "record": "Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia", "subtitle": "NCT05888922", "detail": "Conditions: Androgenetic Alopecia; Female Pattern Baldness. Interventions: Minoxidil Tablets; Minoxidil Topical; Placebo oral tablet; Vehicle solution", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Industrial Farmacéutica Cantabria, S.A.", "enrollment": "520", "nctId": "NCT05888922" }, "jurisdiction": null, "date": "2026-09-16T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05888922", "url": "https://clinicaltrials.gov/study/NCT05888922", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.243Z", "change": null, "origin": "automated" }, { "key": "trial:NCT01629498", "record": "Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer", "subtitle": "NCT01629498", "detail": "Conditions: Recurrent Lung Non-Small Cell Carcinoma; Stage II Non-Small Cell Lung Cancer AJCC v7; Stage IIA Non-Small Cell Lung Carcinoma AJCC v7; Stag…. Interventions: Image Guided Radiation Therapy; Image Guided Radiation Therapy; Intensity-Modulated Radiation Therapy; Intensity-Modula…", "status": "Active, not recruiting", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "M.D. Anderson Cancer Center", "enrollment": "146", "nctId": "NCT01629498" }, "jurisdiction": null, "date": "2026-09-16T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT01629498", "url": "https://clinicaltrials.gov/study/NCT01629498", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.071Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06045221", "record": "ACHIEVE-3: A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin", "subtitle": "NCT06045221", "detail": "Conditions: Type 2 Diabetes. Interventions: Orforglipron; Semaglutide", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1698", "nctId": "NCT06045221" }, "jurisdiction": null, "date": "2026-09-15T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06045221", "url": "https://clinicaltrials.gov/study/NCT06045221", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.474Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07155408", "record": "Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation", "subtitle": "NCT07155408", "detail": "Conditions: Androgenetic Alopecia; Wound Healing. Interventions: Povidone-Iodine 10%; Rifamycin SV Sodium", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Elif Asena KANTARCI", "enrollment": "70", "nctId": "NCT07155408" }, "jurisdiction": null, "date": "2026-09-15T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07155408", "url": "https://clinicaltrials.gov/study/NCT07155408", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.264Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05825105", "record": "Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis", "subtitle": "NCT05825105", "detail": "Conditions: Knee Osteoarthritis. Interventions: Platelet-Rich Plasma", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Universidad Nacional de Entre Rios", "enrollment": "111", "nctId": "NCT05825105" }, "jurisdiction": null, "date": "2026-09-15T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05825105", "url": "https://clinicaltrials.gov/study/NCT05825105", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.082Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06649045", "record": "ATTAIN-OSA: A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight", "subtitle": "NCT06649045", "detail": "Conditions: OSA; Overweight or Obesity. Interventions: Orforglipron; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "712", "nctId": "NCT06649045" }, "jurisdiction": null, "date": "2026-09-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06649045", "url": "https://clinicaltrials.gov/study/NCT06649045", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.500Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07815678", "record": "First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671", "subtitle": "NCT07815678", "detail": "Conditions: Obesity. Interventions: ACCG-2671; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics", "enrollment": "164", "nctId": "NCT07815678" }, "jurisdiction": null, "date": "2026-09-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07815678", "url": "https://clinicaltrials.gov/study/NCT07815678", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.076Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07575932", "record": "SOLIS-1: A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity", "subtitle": "NCT07575932", "detail": "Conditions: Overweight; Obesity; Overweight and/or Obesity; Overweight or Obesity; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseas…. Interventions: PF-08653945; PF-08653944; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 2", "sponsor": "Pfizer", "enrollment": "940", "nctId": "NCT07575932" }, "jurisdiction": null, "date": "2026-09-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07575932", "url": "https://clinicaltrials.gov/study/NCT07575932", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.060Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07817277", "record": "TrichoscopyDM2: Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination", "subtitle": "NCT07817277", "detail": "Conditions: Diabete Mellitus; Female Androgenetic Alopecia; Dermoscopy", "status": "Not yet recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Al-Azhar University", "enrollment": "130", "nctId": "NCT07817277" }, "jurisdiction": null, "date": "2026-09-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07817277", "url": "https://clinicaltrials.gov/study/NCT07817277", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.283Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07793019", "record": "IBI3042 Study in Healthy Participants and Overweight or Obese Participants", "subtitle": "NCT07793019", "detail": "Conditions: Overweight; Healthy Participants; Obesity. Interventions: Orforglipron; Matching Placebo; IBI3042", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "enrollment": "104", "nctId": "NCT07793019" }, "jurisdiction": null, "date": "2026-09-11T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07793019", "url": "https://clinicaltrials.gov/study/NCT07793019", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.519Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07368686", "record": "Topical Multivitamin Serum for Skin Heath", "subtitle": "NCT07368686", "detail": "Conditions: Aesthetic. Interventions: Microneedeling with topical application of VAMP(TM) ADVANCED Topical Multivitamin Serum", "status": "Completed", "fields": { "phase": "Phase 4", "sponsor": "Erevna Innovations Inc.", "enrollment": "30", "nctId": "NCT07368686" }, "jurisdiction": null, "date": "2026-09-11T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07368686", "url": "https://clinicaltrials.gov/study/NCT07368686", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.102Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06284993", "record": "Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis", "subtitle": "NCT06284993", "detail": "Conditions: Plantar Fasciitis, Chronic. Interventions: electroacupuncture(more frequent); electroacupuncture(less frequent)", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Guang'anmen Hospital of China Academy of Chinese Medical Sciences", "enrollment": "80", "nctId": "NCT06284993" }, "jurisdiction": null, "date": "2026-09-11T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06284993", "url": "https://clinicaltrials.gov/study/NCT06284993", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.092Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06836284", "record": "The Evira Study: Additional Support During Obesity Treatment", "subtitle": "NCT06836284", "detail": "Conditions: Childhood Obesity; Treatment Adherence. Interventions: Digi-physical treatment tool, Evira; Obesity medication with liraglutide or semaglutide", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Karolinska Institutet", "enrollment": "40", "nctId": "NCT06836284" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06836284", "url": "https://clinicaltrials.gov/study/NCT06836284", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.866Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07184086", "record": "A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet", "subtitle": "NCT07184086", "detail": "Conditions: Obesity. Interventions: CagriSema (Cagrilintide B + semaglutide I); Low Energy Diet", "status": "Active, not recruiting", "fields": { "phase": "Phase 1", "sponsor": "Novo Nordisk A/S", "enrollment": "80", "nctId": "NCT07184086" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07184086", "url": "https://clinicaltrials.gov/study/NCT07184086", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.130Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06797869", "record": "A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy", "subtitle": "NCT06797869", "detail": "Conditions: Diabetes Mellitus, Type 2; Diabetic Peripheral Neuropathy. Interventions: CagriSema (Cagrilintide B and Semaglutide I); Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Novo Nordisk A/S", "enrollment": "142", "nctId": "NCT06797869" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06797869", "url": "https://clinicaltrials.gov/study/NCT06797869", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.113Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07010432", "record": "RAMBO: The Role of the Amylin Analogue Cagrilintide in Bone Metabolism", "subtitle": "NCT07010432", "detail": "Conditions: Obesity. Interventions: Cagrilintide; Semaglutide; Placebo cagrilintide; Placebo semaglutide", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Novo Nordisk A/S", "enrollment": "144", "nctId": "NCT07010432" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07010432", "url": "https://clinicaltrials.gov/study/NCT07010432", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.093Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07210463", "record": "PLATINUM EU: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)", "subtitle": "NCT07210463", "detail": "Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibitors; Membrane Transpor…. Interventions: NT 201; NT 201 Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Merz Aesthetics GmbH", "enrollment": "300", "nctId": "NCT07210463" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07210463", "url": "https://clinicaltrials.gov/study/NCT07210463", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.762Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07122193", "record": "PLATINUM US: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States", "subtitle": "NCT07122193", "detail": "Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibitors; Membrane Transpor…. Interventions: NT 201; NT 201 Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Merz North America, Inc.", "enrollment": "300", "nctId": "NCT07122193" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07122193", "url": "https://clinicaltrials.gov/study/NCT07122193", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.740Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07756346", "record": "Botox in HS: Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa", "subtitle": "NCT07756346", "detail": "Conditions: Hidradenitis Suppurativa (HS). Interventions: Botulinum Toxin A (Allergan, Inc, Irvine CA); Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "University of Massachusetts, Worcester", "enrollment": "40", "nctId": "NCT07756346" }, "jurisdiction": null, "date": "2026-09-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07756346", "url": "https://clinicaltrials.gov/study/NCT07756346", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:14.836Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:15.112Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07282613", "record": "REIMAGINEYOUNG: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes", "subtitle": "NCT07282613", "detail": "Conditions: Diabetes Mellitus, Type 2. Interventions: CagriSema (Cagrilintide B and Semaglutide I); Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "80", "nctId": "NCT07282613" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07282613", "url": "https://clinicaltrials.gov/study/NCT07282613", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.168Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06926842", "record": "Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)", "subtitle": "NCT06926842", "detail": "Conditions: Overweight; Type 2 Diabetes; Obesity. Interventions: Petrelintide; Placebo", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Zealand Pharma", "enrollment": "221", "nctId": "NCT06926842" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06926842", "url": "https://clinicaltrials.gov/study/NCT06926842", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:17.756Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.149Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07756580", "record": "A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines", "subtitle": "NCT07756580", "detail": "Conditions: Glabellar Lines. Interventions: AGN-151586; BOTOX", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "AbbVie", "enrollment": "120", "nctId": "NCT07756580" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07756580", "url": "https://clinicaltrials.gov/study/NCT07756580", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.778Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04764331", "record": "A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia", "subtitle": "NCT04764331", "detail": "Conditions: Central Centrifugal Cicatricial Alopecia. Interventions: Revian Red All LED cap", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Wake Forest University Health Sciences", "enrollment": "5", "nctId": "NCT04764331" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04764331", "url": "https://clinicaltrials.gov/study/NCT04764331", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.340Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07810504", "record": "KDKR26: Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy", "subtitle": "NCT07810504", "detail": "Conditions: Androgenic Alopecia; Female Pattern Hair Loss; Hair Loss. Interventions: Scalp Stimulating Serum; Red Light Hair Growth Cap; Placebo scalp-stimulating serum", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "K. Kay Durairaj, MD, FACS, A Medical Corporation", "enrollment": "40", "nctId": "NCT07810504" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07810504", "url": "https://clinicaltrials.gov/study/NCT07810504", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.320Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07335367", "record": "AGA: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study", "subtitle": "NCT07335367", "detail": "Conditions: Androgenetic Alopecia (AGA). Interventions: Injection of PRP combined with Botulinum Toxin Type A into the alopecic area(s); PRP-only injection into the alopecic a…", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Nanfang Hospital, Southern Medical University", "enrollment": "83", "nctId": "NCT07335367" }, "jurisdiction": null, "date": "2026-09-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07335367", "url": "https://clinicaltrials.gov/study/NCT07335367", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.302Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06481475", "record": "A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines", "subtitle": "NCT06481475", "detail": "Conditions: Moderate to Severe Glabellar Lines. Interventions: YY003; Vehicle Control", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Chongqing Claruvis Pharmaceutical Co., Ltd.", "enrollment": "153", "nctId": "NCT06481475" }, "jurisdiction": null, "date": "2026-09-08T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06481475", "url": "https://clinicaltrials.gov/study/NCT06481475", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.796Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07516561", "record": "MONA: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia", "subtitle": "NCT07516561", "detail": "Conditions: Alopecia, Androgenetic. Interventions: APSMNF 1; APSMNF 2; Eniagor®", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Apsen Farmaceutica S.A.", "enrollment": "336", "nctId": "NCT07516561" }, "jurisdiction": null, "date": "2026-09-08T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07516561", "url": "https://clinicaltrials.gov/study/NCT07516561", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.379Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07806474", "record": "Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia", "subtitle": "NCT07806474", "detail": "Conditions: Androgenic Alopecia; Healthy Adult Male. Interventions: formulation of green tea leaf extract, bamboo shoot extract and selenium-enriched yeast; formulation of grape seed extr…", "status": "Not yet recruiting", "fields": { "phase": "Not applicable", "sponsor": "Activ'inside", "enrollment": "99", "nctId": "NCT07806474" }, "jurisdiction": null, "date": "2026-09-08T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07806474", "url": "https://clinicaltrials.gov/study/NCT07806474", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.360Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05872620", "record": "ATTAIN-2: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes", "subtitle": "NCT05872620", "detail": "Conditions: Obesity; Overweight; Type 2 Diabetes. Interventions: Orforglipron; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1613", "nctId": "NCT05872620" }, "jurisdiction": null, "date": "2026-09-04T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05872620", "url": "https://clinicaltrials.gov/study/NCT05872620", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.540Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05971940", "record": "ACHIEVE-1: A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone", "subtitle": "NCT05971940", "detail": "Conditions: Type 2 Diabetes. Interventions: Orforglipron; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "559", "nctId": "NCT05971940" }, "jurisdiction": null, "date": "2026-09-03T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05971940", "url": "https://clinicaltrials.gov/study/NCT05971940", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.560Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06916793", "record": "A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia", "subtitle": "NCT06916793", "detail": "Conditions: Androgenetic Alopecia. Interventions: CKD-843 dose#1; CKD-843 dose#2; Placebo of CKD-843 dose; Dutasteride Capsules; Placebo of Dutasteride Capsule", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Chong Kun Dang Pharmaceutical", "enrollment": "288", "nctId": "NCT06916793" }, "jurisdiction": null, "date": "2026-09-03T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06916793", "url": "https://clinicaltrials.gov/study/NCT06916793", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.414Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07317544", "record": "Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia", "subtitle": "NCT07317544", "detail": "Conditions: Androgenetic Alopecia (AGA); Healthy Volunteers - Male and Female. Interventions: SAD IV Dose 1 - 150mg ABS201 IV Single Dose; Placebo IV; ABS-201 SC Multiple Doses; Placebo SC Injection", "status": "Recruiting", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "Absci Pty Ltd.", "enrollment": "227", "nctId": "NCT07317544" }, "jurisdiction": null, "date": "2026-09-03T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07317544", "url": "https://clinicaltrials.gov/study/NCT07317544", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.398Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06981936", "record": "This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control", "subtitle": "NCT06981936", "detail": "Conditions: Micronutrient Deficiencies. Interventions: Balance Tablet; Control (placebo)", "status": "Completed", "fields": { "phase": "Phase 4", "sponsor": "General Committee of Teaching Hospitals and Institutes, Egypt", "enrollment": "150", "nctId": "NCT06981936" }, "jurisdiction": null, "date": "2026-09-02T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06981936", "url": "https://clinicaltrials.gov/study/NCT06981936", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.886Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07373054", "record": "Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia", "subtitle": "NCT07373054", "detail": "Conditions: Androgenic Alopecia. Interventions: Topical Minoxidil; Electric Microneedling; Traditional Exosome Lyophilized Powder; Innovative Exosome Lyophilized Powder", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Fujian Medical University Union Hospital", "enrollment": "18", "nctId": "NCT07373054" }, "jurisdiction": null, "date": "2026-09-02T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07373054", "url": "https://clinicaltrials.gov/study/NCT07373054", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.448Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07588243", "record": "A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth", "subtitle": "NCT07588243", "detail": "Conditions: Androgenic Alopecia. Interventions: Low Level Laser Therapy", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "CynosureLutronic", "enrollment": "44", "nctId": "NCT07588243" }, "jurisdiction": null, "date": "2026-09-02T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07588243", "url": "https://clinicaltrials.gov/study/NCT07588243", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.432Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07739537", "record": "PATHS-T2D: PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses", "subtitle": "NCT07739537", "detail": "Conditions: Diabete Type 2; Pharmacogenomic Drug Interaction. Interventions: Orforglipron", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "Massachusetts General Hospital", "enrollment": "100", "nctId": "NCT07739537" }, "jurisdiction": null, "date": "2026-08-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07739537", "url": "https://clinicaltrials.gov/study/NCT07739537", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.583Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07794891", "record": "Study to Assess Participant Satisfaction After Jawline and Neck Treatment", "subtitle": "NCT07794891", "detail": "Conditions: Jawline and Neck Appearance. Interventions: OnabotulinumtoxinA; SKINVIVE; VOLUX; VOLUMA", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "AbbVie", "enrollment": "100", "nctId": "NCT07794891" }, "jurisdiction": null, "date": "2026-08-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07794891", "url": "https://clinicaltrials.gov/study/NCT07794891", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.863Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07795463", "record": "Botulinum Toxin Type A for Wound Healing After Laparoscopic Colectomy", "subtitle": "NCT07795463", "detail": "Conditions: Surgical Wound Healing; Botulinum Toxin, Type A. Interventions: Botulinum toxin type A (Botox®, Allergan)", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Pham Ngoc Thach University of Medicine", "enrollment": "60", "nctId": "NCT07795463" }, "jurisdiction": null, "date": "2026-08-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07795463", "url": "https://clinicaltrials.gov/study/NCT07795463", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.846Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06903975", "record": "BoTox Into the Sternocleidomastoid Muscles (SCM)", "subtitle": "NCT06903975", "detail": "Conditions: Neck Muscle Issue. Interventions: prabotulinumtoxinA-xvfs", "status": "Recruiting", "fields": { "phase": "Phase 4", "sponsor": "Boston Medical Center", "enrollment": "30", "nctId": "NCT06903975" }, "jurisdiction": null, "date": "2026-08-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06903975", "url": "https://clinicaltrials.gov/study/NCT06903975", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.830Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05565950", "record": "AI-09 In Subjects With Glabellar Lines, GL-101", "subtitle": "NCT05565950", "detail": "Conditions: Glabellar Frown Lines. Interventions: AI-09; Vehicle", "status": "Completed", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "Eirion Therapeutics Inc.", "enrollment": "96", "nctId": "NCT05565950" }, "jurisdiction": null, "date": "2026-08-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05565950", "url": "https://clinicaltrials.gov/study/NCT05565950", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.813Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07790861", "record": "ATTAIN-CN: A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems", "subtitle": "NCT07790861", "detail": "Conditions: Obesity; Overweight. Interventions: Orforglipron; Placebo", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "192", "nctId": "NCT07790861" }, "jurisdiction": null, "date": "2026-08-27T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07790861", "url": "https://clinicaltrials.gov/study/NCT07790861", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.603Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07787936", "record": "GLIDE-HF: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry", "subtitle": "NCT07787936", "detail": "Conditions: Heart Failure With Preserved Ejection Fraction; Obesity; Diastolic Heart Failure; Pulmonary Hypertension; Iron Deficiency. Interventions: GLP-1 / GIP receptor agonist", "status": "Not yet recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Miedziowe Centrum Zdrowia SA", "enrollment": "150", "nctId": "NCT07787936" }, "jurisdiction": null, "date": "2026-08-26T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07787936", "url": "https://clinicaltrials.gov/study/NCT07787936", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.904Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07720726", "record": "Impact of Dysport on PMFF Donor Scar", "subtitle": "NCT07720726", "detail": "Conditions: Skin Cancer Excision Site; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma. Interventions: Abobotulinumtoxin-A; Control- Saline injection", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "Vanderbilt University Medical Center", "enrollment": "50", "nctId": "NCT07720726" }, "jurisdiction": null, "date": "2026-08-26T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07720726", "url": "https://clinicaltrials.gov/study/NCT07720726", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.895Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07783763", "record": "Study of DWP450 in Japanese Subjects With Glabellar Lines", "subtitle": "NCT07783763", "detail": "Conditions: Glabellar Lines. Interventions: DWP450 20 U; 0.9% Saline Solution 0.5 mL", "status": "Not yet recruiting", "fields": { "phase": "Phase 3", "sponsor": "Daewoong Pharmaceutical Co. LTD.", "enrollment": "120", "nctId": "NCT07783763" }, "jurisdiction": null, "date": "2026-08-26T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07783763", "url": "https://clinicaltrials.gov/study/NCT07783763", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.879Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05965908", "record": "Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome", "subtitle": "NCT05965908", "detail": "Conditions: Polycystic Ovary. Interventions: liraglutide; Metformin", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Beni-Suef University", "enrollment": "183", "nctId": "NCT05965908" }, "jurisdiction": null, "date": "2026-08-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05965908", "url": "https://clinicaltrials.gov/study/NCT05965908", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.921Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06387394", "record": "MMP US P3 416: A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence", "subtitle": "NCT06387394", "detail": "Conditions: Masseter Muscle Prominence. Interventions: BOTOX; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "AbbVie", "enrollment": "202", "nctId": "NCT06387394" }, "jurisdiction": null, "date": "2026-08-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06387394", "url": "https://clinicaltrials.gov/study/NCT06387394", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.911Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06672939", "record": "A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities", "subtitle": "NCT06672939", "detail": "Conditions: Obesity; Overweight. Interventions: Orforglipron; Placebo", "status": "Recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "150", "nctId": "NCT06672939" }, "jurisdiction": null, "date": "2026-08-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06672939", "url": "https://clinicaltrials.gov/study/NCT06672939", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.621Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05929066", "record": "TRIUMPH-1: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight", "subtitle": "NCT05929066", "detail": "Conditions: Obesity; Overweight; Osteoarthritis, Knee; Obstructive Sleep Apnea. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "2335", "nctId": "NCT05929066" }, "jurisdiction": null, "date": "2026-08-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05929066", "url": "https://clinicaltrials.gov/study/NCT05929066", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.385Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07580521", "record": "Microneedling for Androgenic Alopecia: a Clinical Study", "subtitle": "NCT07580521", "detail": "Conditions: Androgenic Alopecia. Interventions: Microneedling monotherapy without drugs", "status": "Active, not recruiting", "fields": { "phase": "Not applicable", "sponsor": "Taipei Medical University WanFang Hospital", "enrollment": "25", "nctId": "NCT07580521" }, "jurisdiction": null, "date": "2026-08-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07580521", "url": "https://clinicaltrials.gov/study/NCT07580521", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.468Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07776015", "record": "EXO-MINO: Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia", "subtitle": "NCT07776015", "detail": "Conditions: Androgenetic Alopecia; Exosomes. Interventions: exosomes injection; Topical Minoxidil 5%", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Tanta University", "enrollment": "40", "nctId": "NCT07776015" }, "jurisdiction": null, "date": "2026-08-20T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07776015", "url": "https://clinicaltrials.gov/study/NCT07776015", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.128Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.486Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07213323", "record": "PROBIO-GLP1: Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment", "subtitle": "NCT07213323", "detail": "Conditions: Obesity &Amp; Overweight; Digestive Disorders. Interventions: Probiotics (Natural product); Placebo", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Hospices Civils de Lyon", "enrollment": "50", "nctId": "NCT07213323" }, "jurisdiction": null, "date": "2026-08-19T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07213323", "url": "https://clinicaltrials.gov/study/NCT07213323", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.939Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05869903", "record": "ATTAIN-1: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities", "subtitle": "NCT05869903", "detail": "Conditions: Obesity; Overweight; Overweight or Obesity. Interventions: Orforglipron; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "3127", "nctId": "NCT05869903" }, "jurisdiction": null, "date": "2026-08-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05869903", "url": "https://clinicaltrials.gov/study/NCT05869903", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.642Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06448676", "record": "Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides", "subtitle": "NCT06448676", "detail": "Conditions: Wrinkle; Glabellar Frown Lines; Glabellar Furrowing. Interventions: Botulinum toxin type A", "status": "Recruiting", "fields": { "phase": "Phase 4", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "enrollment": "325", "nctId": "NCT06448676" }, "jurisdiction": null, "date": "2026-08-14T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06448676", "url": "https://clinicaltrials.gov/study/NCT06448676", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.928Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05220917", "record": "CER-4-T2D: Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study", "subtitle": "NCT05220917", "detail": "Conditions: Cardiovascular Events; Type2 Diabetes; Renal Disease. Interventions: SGLT2 inhibitor; DPP-4 inhibitor; GLP-1RA; 2nd generation SU", "status": "Active, not recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Brigham and Women's Hospital", "enrollment": "781430", "nctId": "NCT05220917" }, "jurisdiction": null, "date": "2026-08-13T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05220917", "url": "https://clinicaltrials.gov/study/NCT05220917", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.959Z", "change": null, "origin": "automated" }, { "key": "trial:NCT03883412", "record": "ZQL007: Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)", "subtitle": "NCT03883412", "detail": "Conditions: Type2 Diabetes. Interventions: Exercise; Liraglutide", "status": "Recruiting", "fields": { "phase": "Phase 4", "sponsor": "University of Virginia", "enrollment": "60", "nctId": "NCT03883412" }, "jurisdiction": null, "date": "2026-08-12T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT03883412", "url": "https://clinicaltrials.gov/study/NCT03883412", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.988Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06385171", "record": "Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation", "subtitle": "NCT06385171", "detail": "Conditions: Wrinkle. Interventions: Botulinum toxin type A", "status": "Withdrawn", "fields": { "phase": "Phase not stated", "sponsor": "Global Aesthetics LLC", "enrollment": null, "nctId": "NCT06385171" }, "jurisdiction": null, "date": "2026-08-12T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06385171", "url": "https://clinicaltrials.gov/study/NCT06385171", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.964Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06399718", "record": "MMP US P3 417: A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants", "subtitle": "NCT06399718", "detail": "Conditions: Masseter Muscle Prominence. Interventions: BOTOX; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "AbbVie", "enrollment": "207", "nctId": "NCT06399718" }, "jurisdiction": null, "date": "2026-08-12T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06399718", "url": "https://clinicaltrials.gov/study/NCT06399718", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.946Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07629401", "record": "Pre-approval Expanded Access of Retatrutide (LY3437943)", "subtitle": "NCT07629401", "detail": "Conditions: Obesity; Obesity-related Complications. Interventions: Retatrutide", "status": "available", "fields": { "phase": "Phase not stated", "sponsor": "Eli Lilly and Company", "enrollment": null, "nctId": "NCT07629401" }, "jurisdiction": null, "date": "2026-08-06T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07629401", "url": "https://clinicaltrials.gov/study/NCT07629401", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.404Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05313529", "record": "LIGHT-MCI: LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes", "subtitle": "NCT05313529", "detail": "Conditions: Type 2 Diabetes Mellitus; Mild Cognitive Impairment. Interventions: Liraglutide; Empagliflozin; Linagliptin", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "enrollment": "396", "nctId": "NCT05313529" }, "jurisdiction": null, "date": "2026-08-06T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05313529", "url": "https://clinicaltrials.gov/study/NCT05313529", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.009Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06374875", "record": "FLAMES: Fibrosis Lessens After Metabolic Surgery", "subtitle": "NCT06374875", "detail": "Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steat…. Interventions: Metabolic surgery; Incretin-Based Therapy", "status": "Recruiting", "fields": { "phase": "Phase 4", "sponsor": "The Cleveland Clinic", "enrollment": "120", "nctId": "NCT06374875" }, "jurisdiction": null, "date": "2026-07-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06374875", "url": "https://clinicaltrials.gov/study/NCT06374875", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.029Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06993792", "record": "A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes", "subtitle": "NCT06993792", "detail": "Conditions: Obesity; Overweight; Type 2 Diabetes. Interventions: Orforglipron; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1400", "nctId": "NCT06993792" }, "jurisdiction": null, "date": "2026-07-31T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06993792", "url": "https://clinicaltrials.gov/study/NCT06993792", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.660Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05929079", "record": "TRIUMPH-2: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight", "subtitle": "NCT05929079", "detail": "Conditions: Type 2 Diabetes; Obesity; Overweight; Obstructive Sleep Apnea. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1152", "nctId": "NCT05929079" }, "jurisdiction": null, "date": "2026-07-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05929079", "url": "https://clinicaltrials.gov/study/NCT05929079", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.439Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05882045", "record": "TRIUMPH-3: A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease", "subtitle": "NCT05882045", "detail": "Conditions: Obesity; Cardiovascular Diseases. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "1946", "nctId": "NCT05882045" }, "jurisdiction": null, "date": "2026-07-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05882045", "url": "https://clinicaltrials.gov/study/NCT05882045", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.422Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06972459", "record": "A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity", "subtitle": "NCT06972459", "detail": "Conditions: Obesity; Overweight. Interventions: Orforglipron; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "800", "nctId": "NCT06972459" }, "jurisdiction": null, "date": "2026-07-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06972459", "url": "https://clinicaltrials.gov/study/NCT06972459", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.678Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07729332", "record": "Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation", "subtitle": "NCT07729332", "detail": "Conditions: Obesity. Interventions: Phentermine Pill; Orforglipron", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "Massachusetts General Hospital", "enrollment": "60", "nctId": "NCT07729332" }, "jurisdiction": null, "date": "2026-07-27T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07729332", "url": "https://clinicaltrials.gov/study/NCT07729332", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.316Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:18.696Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05892770", "record": "Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia", "subtitle": "NCT05892770", "detail": "Conditions: Spasmodic Dysphonia. Interventions: Zinc gluconate supplement; Botulinum toxin type A", "status": "Completed", "fields": { "phase": "Phase 1 / Phase 2", "sponsor": "University of Florida", "enrollment": "32", "nctId": "NCT05892770" }, "jurisdiction": null, "date": "2026-07-27T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05892770", "url": "https://clinicaltrials.gov/study/NCT05892770", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:16.982Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07702461", "record": "Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists", "subtitle": "NCT07702461", "detail": "Conditions: Obesity & Overweight; Diabetes (DM). Interventions: Glucagon-Like Peptide-1 Agonist (GLP-1)", "status": "Recruiting", "fields": { "phase": "Phase not stated", "sponsor": "Ohio State University", "enrollment": "300", "nctId": "NCT07702461" }, "jurisdiction": null, "date": "2026-07-24T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07702461", "url": "https://clinicaltrials.gov/study/NCT07702461", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.046Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07225816", "record": "Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)", "subtitle": "NCT07225816", "detail": "Conditions: Obesity. Interventions: Liraglutide; Oral Semaglutide; Semaglutide", "status": "Recruiting", "fields": { "phase": "Phase 1", "sponsor": "Novo Nordisk A/S", "enrollment": "71", "nctId": "NCT07225816" }, "jurisdiction": null, "date": "2026-07-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07225816", "url": "https://clinicaltrials.gov/study/NCT07225816", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.065Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07715331", "record": "Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display", "subtitle": "NCT07715331", "detail": "Conditions: Excessive Gingival Display; Gingival Diseases; Gummy Smile; Esthetics, Dental. Interventions: Botulinum Toxin Type A (Refinex®); Cross-Linked Hyaluronic Acid Filler (Juvéderm Voluma® with Lidocaine)", "status": "Completed", "fields": { "phase": "Not applicable", "sponsor": "Al-Azhar University", "enrollment": "20", "nctId": "NCT07715331" }, "jurisdiction": null, "date": "2026-07-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07715331", "url": "https://clinicaltrials.gov/study/NCT07715331", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.003Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06297603", "record": "Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)", "subtitle": "NCT06297603", "detail": "Conditions: Type 2 Diabetes. Interventions: Retatrutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "320", "nctId": "NCT06297603" }, "jurisdiction": null, "date": "2026-07-20T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06297603", "url": "https://clinicaltrials.gov/study/NCT06297603", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.504Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06662383", "record": "TRIUMPH-5: A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity", "subtitle": "NCT06662383", "detail": "Conditions: Obesity. Interventions: Retatrutide; Tirzepatide", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "800", "nctId": "NCT06662383" }, "jurisdiction": null, "date": "2026-07-20T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06662383", "url": "https://clinicaltrials.gov/study/NCT06662383", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.459Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06982859", "record": "A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus", "subtitle": "NCT06982859", "detail": "Conditions: Diabetes Mellitus; Insulin Sensitivity. Interventions: Retatrutide; Semaglutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 1", "sponsor": "Eli Lilly and Company", "enrollment": "95", "nctId": "NCT06982859" }, "jurisdiction": null, "date": "2026-07-16T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06982859", "url": "https://clinicaltrials.gov/study/NCT06982859", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.542Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04775082", "record": "SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity", "subtitle": "NCT04775082", "detail": "Conditions: Obesity. Interventions: Liraglutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Novo Nordisk A/S", "enrollment": "78", "nctId": "NCT04775082" }, "jurisdiction": null, "date": "2026-07-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04775082", "url": "https://clinicaltrials.gov/study/NCT04775082", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.085Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07646886", "record": "Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis", "subtitle": "NCT07646886", "detail": "Conditions: Facial Aging; Melomental Folds; Oral Commissure Ptosis. Interventions: OnabotulinumtoxinA (Upper Depressor Anguli Oris Injection); OnabotulinumtoxinA (Lower Depressor Anguli Oris Injection)", "status": "Not yet recruiting", "fields": { "phase": "Phase 4", "sponsor": "Peking University", "enrollment": "266", "nctId": "NCT07646886" }, "jurisdiction": null, "date": "2026-07-07T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07646886", "url": "https://clinicaltrials.gov/study/NCT07646886", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:16.638Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:17.021Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07677865", "record": "GLP1-AD-TTE: GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation", "subtitle": "NCT07677865", "detail": "Conditions: Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight. Interventions: GLP-1 Receptor Agonists; DPP-4 Inhibitors", "status": "Completed", "fields": { "phase": "Phase not stated", "sponsor": "West China Hospital", "enrollment": "213891", "nctId": "NCT07677865" }, "jurisdiction": null, "date": "2026-07-01T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07677865", "url": "https://clinicaltrials.gov/study/NCT07677865", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.104Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06982846", "record": "A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia", "subtitle": "NCT06982846", "detail": "Conditions: Type 2 Diabetes Mellitus. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 1", "sponsor": "Eli Lilly and Company", "enrollment": "80", "nctId": "NCT06982846" }, "jurisdiction": null, "date": "2026-06-18T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06982846", "url": "https://clinicaltrials.gov/study/NCT06982846", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.586Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07640139", "record": "Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes", "subtitle": "NCT07640139", "detail": "Conditions: Obesity. Interventions: Incretin-based therapies (GLP-1 and GLP-1/GIP)", "status": "Enrolling by invitation", "fields": { "phase": "Phase not stated", "sponsor": "Indiana University", "enrollment": "125000", "nctId": "NCT07640139" }, "jurisdiction": null, "date": "2026-06-10T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07640139", "url": "https://clinicaltrials.gov/study/NCT07640139", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.123Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07357415", "record": "TRIUMPH-9: A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight", "subtitle": "NCT07357415", "detail": "Conditions: Obesity; Overweight. Interventions: Retatrutide", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "600", "nctId": "NCT07357415" }, "jurisdiction": null, "date": "2026-06-09T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07357415", "url": "https://clinicaltrials.gov/study/NCT07357415", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.606Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07107334", "record": "A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia", "subtitle": "NCT07107334", "detail": "Conditions: Endometrioid Endometrial Adenocarcinoma. Interventions: Glucagon-like peptide 1 receptor agonist", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "University of Florida", "enrollment": "20", "nctId": "NCT07107334" }, "jurisdiction": null, "date": "2026-06-08T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07107334", "url": "https://clinicaltrials.gov/study/NCT07107334", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.141Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07613437", "record": "GLICH: GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial", "subtitle": "NCT07613437", "detail": "Conditions: Intracerebral Hemorrhage. Interventions: Semaglutide, 0.5 mg/mL", "status": "Not yet recruiting", "fields": { "phase": "Phase 2", "sponsor": "Chinese University of Hong Kong", "enrollment": "200", "nctId": "NCT07613437" }, "jurisdiction": null, "date": "2026-05-29T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07613437", "url": "https://clinicaltrials.gov/study/NCT07613437", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.159Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07590219", "record": "Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity", "subtitle": "NCT07590219", "detail": "Conditions: Severe Obesity; Cardiovascular Function; Liraglutide; Childhood Obesity; Echocardiography; Speckle Tracking. Interventions: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml", "status": "Active, not recruiting", "fields": { "phase": "Phase 4", "sponsor": "University of Sao Paulo General Hospital", "enrollment": "30", "nctId": "NCT07590219" }, "jurisdiction": null, "date": "2026-05-15T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07590219", "url": "https://clinicaltrials.gov/study/NCT07590219", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.178Z", "change": null, "origin": "automated" }, { "key": "trial:NCT04575844", "record": "ZQL008: Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome", "subtitle": "NCT04575844", "detail": "Conditions: Metabolic Syndrome. Interventions: Liraglutide; Exercise training; Liraglutide + Exercise training", "status": "Recruiting", "fields": { "phase": "Phase 4", "sponsor": "University of Virginia", "enrollment": "80", "nctId": "NCT04575844" }, "jurisdiction": null, "date": "2026-05-06T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT04575844", "url": "https://clinicaltrials.gov/study/NCT04575844", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:18.824Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.196Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07232719", "record": "TRIUMPH-8: A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight", "subtitle": "NCT07232719", "detail": "Conditions: Obesity; Overweight. Interventions: Retatrutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "250", "nctId": "NCT07232719" }, "jurisdiction": null, "date": "2026-04-17T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07232719", "url": "https://clinicaltrials.gov/study/NCT07232719", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.626Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07467447", "record": "GZBF: Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight", "subtitle": "NCT07467447", "detail": "Conditions: Obesity. Interventions: Retatrutide (LY3437943); Placebo; Standardized diet and physical activity counseling throughout the study.", "status": "Recruiting", "fields": { "phase": "Phase 2", "sponsor": "Hudson Biotech", "enrollment": "300", "nctId": "NCT07467447" }, "jurisdiction": null, "date": "2026-03-12T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07467447", "url": "https://clinicaltrials.gov/study/NCT07467447", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.645Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06354660", "record": "Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)", "subtitle": "NCT06354660", "detail": "Conditions: Diabetes Type 2. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "537", "nctId": "NCT06354660" }, "jurisdiction": null, "date": "2026-03-05T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06354660", "url": "https://clinicaltrials.gov/study/NCT06354660", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.664Z", "change": null, "origin": "automated" }, { "key": "trial:NCT06859268", "record": "TRIUMPH-6: A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity", "subtitle": "NCT06859268", "detail": "Conditions: Obesity. Interventions: Retatrutide; Placebo", "status": "Active, not recruiting", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "643", "nctId": "NCT06859268" }, "jurisdiction": null, "date": "2026-03-03T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT06859268", "url": "https://clinicaltrials.gov/study/NCT06859268", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.684Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05931367", "record": "TRIUMPH-4: A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee", "subtitle": "NCT05931367", "detail": "Conditions: Obesity; Overweight; Osteo Arthritis Knee. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 3", "sponsor": "Eli Lilly and Company", "enrollment": "445", "nctId": "NCT05931367" }, "jurisdiction": null, "date": "2026-01-21T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05931367", "url": "https://clinicaltrials.gov/study/NCT05931367", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.705Z", "change": null, "origin": "automated" }, { "key": "trial:NCT07226947", "record": "BICEP: Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment", "subtitle": "NCT07226947", "detail": "Conditions: Obesity; Body Composition. Interventions: Smartwatch activity and body composition monitor; General guidance on recommended exercise", "status": "Recruiting", "fields": { "phase": "Not applicable", "sponsor": "Massachusetts General Hospital", "enrollment": "100", "nctId": "NCT07226947" }, "jurisdiction": null, "date": "2025-12-30T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT07226947", "url": "https://clinicaltrials.gov/study/NCT07226947", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.724Z", "change": null, "origin": "automated" }, { "key": "trial:NCT05936151", "record": "A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes", "subtitle": "NCT05936151", "detail": "Conditions: Overweight or Obesity; CKD; Type 2 Diabetes. Interventions: Retatrutide; Placebo", "status": "Completed", "fields": { "phase": "Phase 2", "sponsor": "Eli Lilly and Company", "enrollment": "146", "nctId": "NCT05936151" }, "jurisdiction": null, "date": "2025-11-25T00:00:00.000Z", "dateType": "Last update posted", "source": { "title": "ClinicalTrials.gov record NCT05936151", "url": "https://clinicaltrials.gov/study/NCT05936151", "publisher": "ClinicalTrials.gov (U.S. National Library of Medicine)", "type": "Primary source" }, "lastChecked": "2026-10-01T09:05:19.292Z", "checkedBy": "system", "nphlaUpdatedAt": "2026-10-01T09:05:19.742Z", "change": null, "origin": "automated" } ] }